Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03453489Phase 2Completed
AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm
Carcinoid SyndromeMetastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
PrincipalinvestigatorStart date: 2018-06-20
NCT02620865Phase 1/2Completed
BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage III Pancreatic Cancer+1 more
Principalinvestigator
NCT02819024Not ApplicableCompleted
Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography
Recurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer+1 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung CancerStage IV Pancreatic Cancer
Similarity Score6%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Stage III Pancreatic CancerStage IV Pancreatic Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

Stage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Similarity Score6%

Ido Wolf, MD

Tel-Aviv Sourasky Medical Center

Related
1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer
Similarity Score3%

Antony Magliocco, MD

Protean BioDiagnostics

Related
1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer
Similarity Score3%

Eugenie Younger, MD

Gloucestershire Hospitals NHS Foundation Trust

Related
1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer
Similarity Score3%

Andreas Polychronis, MD

Mount Vernon Cancer Centre

Related
1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer
Similarity Score3%

Adam Berger, MD

Rutgers Cancer Institute

Related
1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer
Similarity Score3%

Astrid Ammendola, MD

Asklepios Klinik Gauting GmbH

Related
1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer
Similarity Score3%

Igor Puzanov, MD

Roswell Park

Related
1 trials

Shared therapeutic areas:

Stage IV Non-small Cell Lung Cancer
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03453489Phase 2PrincipalInvestigator

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

Carcinoid SyndromeMetastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
Completed
NCT02620865Phase 1/2PrincipalInvestigator

BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer

Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage III Pancreatic Cancer+1 more
Completed
NCT02819024Not ApplicablePrincipalInvestigator

Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography

Recurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer+1 more
Completed

All 3 trials loaded